Personalizing cancer care: updates on head and neck cancer.
With an emphasis on personalizing cancer care, the American Society of Clinical Oncology 45th Annual Meeting was held from 29 May to 2 June in Orlando (FL, USA). Several abstracts were presented that will significantly impact the management of squamous cell carcinoma of the head and neck both currently and in the near future, especially with respect to patient selection for specific therapies, prognostic biomarkers and novel agents.
de Souza
Jonas A
JA
University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637, USA. jonas.desouza@uchospitals.edu
Cohen
Ezra E
EE
D014408:Biomarkers, Tumor / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy*; D002986:Clinical Trials as Topic; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D018579:Patient Selection; D011379:Prognosis
D014408:Biomarkers, Tumor